204 related articles for article (PubMed ID: 15831699)
61. A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.
Kumaki S; Ochs HD; Kuropatwinski KK; Konno T; Timour MS; Cosman D; Baumann H
Clin Exp Immunol; 1999 Feb; 115(2):356-61. PubMed ID: 9933465
[TBL] [Abstract][Full Text] [Related]
62. Janus kinase 3 regulates adherens junctions and epithelial mesenchymal transition through β-catenin.
Mishra J; Das JK; Kumar N
J Biol Chem; 2017 Oct; 292(40):16406-16419. PubMed ID: 28821617
[TBL] [Abstract][Full Text] [Related]
63. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells.
Lai KS; Jin Y; Graham DK; Witthuhn BA; Ihle JN; Liu ET
J Biol Chem; 1995 Oct; 270(42):25028-36. PubMed ID: 7559633
[TBL] [Abstract][Full Text] [Related]
64. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
[TBL] [Abstract][Full Text] [Related]
65. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
[TBL] [Abstract][Full Text] [Related]
66. Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited.
Hofmann SR; Lam AQ; Frank S; Zhou YJ; Ramos HL; Kanno Y; Agnello D; Youle RJ; O'Shea JJ
Mol Cell Biol; 2004 Jun; 24(11):5039-49. PubMed ID: 15143194
[TBL] [Abstract][Full Text] [Related]
67. Mechanism of Janus kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation loop peptide.
Wang R; Griffin PR; Small EC; Thompson JE
Arch Biochem Biophys; 2003 Feb; 410(1):7-15. PubMed ID: 12559972
[TBL] [Abstract][Full Text] [Related]
68. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis.
Thomis DC; Lee W; Berg LJ
J Immunol; 1997 Nov; 159(10):4708-19. PubMed ID: 9366394
[TBL] [Abstract][Full Text] [Related]
69. Activation of the interleukin 2 receptor: a possible role for tyrosine phosphatases.
Ellery JM; Kempshall SJ; Nicholls PJ
Cell Signal; 2000 Jun; 12(6):367-73. PubMed ID: 10889465
[TBL] [Abstract][Full Text] [Related]
70. Jak3 activation in human lymphocyte precursor cells.
Sharfe N; Dadi HK; O'Shea JJ; Roifman CM
Clin Exp Immunol; 1997 Jun; 108(3):552-6. PubMed ID: 9182906
[TBL] [Abstract][Full Text] [Related]
71. Crystal structures of the phosphorylated and unphosphorylated kinase domains of the Cdc42-associated tyrosine kinase ACK1.
Lougheed JC; Chen RH; Mak P; Stout TJ
J Biol Chem; 2004 Oct; 279(42):44039-45. PubMed ID: 15308621
[TBL] [Abstract][Full Text] [Related]
72. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
[TBL] [Abstract][Full Text] [Related]
73. Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6.
Chrencik JE; Patny A; Leung IK; Korniski B; Emmons TL; Hall T; Weinberg RA; Gormley JA; Williams JM; Day JE; Hirsch JL; Kiefer JR; Leone JW; Fischer HD; Sommers CD; Huang HC; Jacobsen EJ; Tenbrink RE; Tomasselli AG; Benson TE
J Mol Biol; 2010 Jul; 400(3):413-33. PubMed ID: 20478313
[TBL] [Abstract][Full Text] [Related]
74. VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease.
Mahajan S; Hogan JK; Shlyakhter D; Oh L; Salituro FG; Farmer L; Hoock TC
J Pharmacol Exp Ther; 2015 May; 353(2):405-14. PubMed ID: 25762693
[TBL] [Abstract][Full Text] [Related]
75. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
Sasaki A; Yasukawa H; Suzuki A; Kamizono S; Syoda T; Kinjyo I; Sasaki M; Johnston JA; Yoshimura A
Genes Cells; 1999 Jun; 4(6):339-51. PubMed ID: 10421843
[TBL] [Abstract][Full Text] [Related]
76. Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutations.
Hammarén HM; Virtanen AT; Abraham BG; Peussa H; Hubbard SR; Silvennoinen O
J Allergy Clin Immunol; 2019 Apr; 143(4):1549-1559.e6. PubMed ID: 30092288
[TBL] [Abstract][Full Text] [Related]
77. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
Li WQ; Dehnade F; Zafarullah M
J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
[TBL] [Abstract][Full Text] [Related]
78. Insights into kinetic mechanism of Janus kinase 3 and its inhibition by tofacitinib.
Hekmatnejad M; Conwell S; Lok SM; Kutach A; Shaw D; Fang E; Swinney DC
Arch Biochem Biophys; 2016 Dec; 612():22-34. PubMed ID: 27555492
[TBL] [Abstract][Full Text] [Related]
79. Phosphorylation of Tyrosine 841 Plays a Significant Role in JAK3 Activation.
Sun S; Rodriguez G; Xie Y; Guo W; Hernandez AEL; Sanchez JE; Kirken RA; Li L
Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109511
[TBL] [Abstract][Full Text] [Related]
80. Specific Jak3 Downregulation in Lymphocytes Impairs γc Cytokine Signal Transduction and Alleviates Antigen-driven Inflammation In Vivo.
Gómez-Valadés AG; Llamas M; Blanch S; Perales JC; Román J; Gómez-Casajús L; Mascaró C
Mol Ther Nucleic Acids; 2012 Sep; 1(9):e42. PubMed ID: 23344234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
